Hui Li, Ph.D.

Co-Funded with St. Baldrick’s Foundation

Alveolar rhabdomyosarcoma is one of the most common children tumors.  No effective therapy is available for advanced disease.  Poor understanding of the etiology of the tumor is partly responsible for the lack of advancement in treatment.  We are using tumor-signature events to study the cell of origin for the disease.  Our results may shed light on the development of the tumor, and potentially lead to better diagnostic and therapeutic tools. 

Location: University of Virginia -
Proposal: Gene Fusions in Rhabdomyosarcoma
Mailing List Mailing List
Close Mailing List